Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia (DOLF-LIBERIA)
Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Liberia
Sponsor: Washington University School of Medicine
A observational or N/A phase clinical study on Lymphatic Filariasis and Onchocerciasis, this trial is completed. The trial is conducted by Washington University School of Medicine and has accumulated 14 data snapshots since 2012. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Mar 2022 — Jul 2024 [monthly]
Completed
Status: Enrolling By Invitation → Completed
-
Dec 2021 — Mar 2022 [monthly]
Enrolling By Invitation
-
Jan 2021 — Dec 2021 [monthly]
Enrolling By Invitation
▶ Show 9 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Enrolling By Invitation
-
Nov 2020 — Dec 2020 [monthly]
Enrolling By Invitation
-
Feb 2020 — Nov 2020 [monthly]
Enrolling By Invitation
Status: Completed → Enrolling By Invitation
-
Jun 2018 — Feb 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jun 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Jun 2017 [monthly]
Recruiting NA
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .